Pembrolizumab vs chemotherapy for MSI-high/dMMR metastatic colorectal cancer: Asia subgroup of phase 3 KEYNOTE-177

Simple item page
dc.conference.dateFEB 18-21, 2021
dc.conference.titleAnnual Meeting of the Japanese-Society-of-Medical-Oncology (JSMO)
dc.contributor.authorYoshino, Takayuki
dc.contributor.authorKim, Tae Won
dc.contributor.authorYong, Wei Peng
dc.contributor.authorShiu, Kai-Keen
dc.contributor.authorJensen, Benny Vittrup
dc.contributor.authorJensen, Lars Henrik
dc.contributor.authorSmith, Denis
dc.contributor.authorGarcia-Carbonero, Rocio
dc.contributor.authorAlcaide-Garcia, Julia
dc.contributor.authorGibbs, Peter
dc.contributor.authorDe la Fouchardiere, Christelle
dc.contributor.authorRivera, Fernando
dc.contributor.authorElez, Elena
dc.contributor.authorBendell, Johanna
dc.contributor.authorLe, Dung T.
dc.contributor.authorYang, Ping
dc.contributor.authorFarooqui, Mohammed
dc.contributor.authorMarinello, Patricia
dc.contributor.authorDiaz, Luis A.
dc.contributor.authorAndre, Thierry
dc.contributor.authoraffiliation[Yoshino, Takayuki] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
dc.contributor.authoraffiliation[Kim, Tae Won] Asan Med Ctr, Seoul, South Korea
dc.contributor.authoraffiliation[Yong, Wei Peng] Natl Univ Singapore Hosp, Singapore, Singapore
dc.contributor.authoraffiliation[Shiu, Kai-Keen] NHS Fdn Trust, Univ Coll Hosp, London, England
dc.contributor.authoraffiliation[Jensen, Benny Vittrup] Herlev & Gentofte Hosp, Herlev, Denmark
dc.contributor.authoraffiliation[Jensen, Lars Henrik] Univ Hosp Southern Denmark, Odense, Denmark
dc.contributor.authoraffiliation[Smith, Denis] Hop Haut Leveque, Pessac, France
dc.contributor.authoraffiliation[Garcia-Carbonero, Rocio] UCM, Hosp Univ 12 Octubre, Imas12, Madrid, Spain
dc.contributor.authoraffiliation[Alcaide-Garcia, Julia] Hosp Reg Univ, Malaga, Spain
dc.contributor.authoraffiliation[Gibbs, Peter] Western Hosp, Henley Beach, Australia
dc.contributor.authoraffiliation[De la Fouchardiere, Christelle] Ctr Leon Berard, Lyon, France
dc.contributor.authoraffiliation[Rivera, Fernando] Hosp Univ Marques de Valdecilla, IDIVAL, Santander, Spain
dc.contributor.authoraffiliation[Elez, Elena] Vall DHebron Inst Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Bendell, Johanna] Sarah Cannon Res Inst, Nashville, TN USA
dc.contributor.authoraffiliation[Le, Dung T.] Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
dc.contributor.authoraffiliation[Yang, Ping] Merck & Co Inc, Kenilworth, NJ USA
dc.contributor.authoraffiliation[Farooqui, Mohammed] Merck & Co Inc, Kenilworth, NJ USA
dc.contributor.authoraffiliation[Marinello, Patricia] Merck & Co Inc, Kenilworth, NJ USA
dc.contributor.authoraffiliation[Diaz, Luis A.] Mem Sloan Kettering Canc Ctr, New York, NY USA
dc.contributor.authoraffiliation[Andre, Thierry] Hop St Antoine, Paris, France
dc.date.accessioned2025-01-07T12:14:41Z
dc.date.available2025-01-07T12:14:41Z
dc.date.issued2021-07-26
dc.identifier.doi10.1016/j.annonc.2021.05.518
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S092375342101718X/pdf
dc.identifier.urihttps://hdl.handle.net/10668/24354
dc.identifier.wosID683609100106
dc.issue.number4
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.page.numberS284-S284
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titlePembrolizumab vs chemotherapy for MSI-high/dMMR metastatic colorectal cancer: Asia subgroup of phase 3 KEYNOTE-177
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía